S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Income Expert and Author of Get Rich With Dividends Is Giving Away His Top Income Secrets… FOR FREE! (Ad)
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Income Expert and Author of Get Rich With Dividends Is Giving Away His Top Income Secrets… FOR FREE! (Ad)
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
Stock market today: Asian shares mostly decline, while Tokyo again touches a record high
What recession? Professional forecasters raise expectations for US economy in 2024
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Income Expert and Author of Get Rich With Dividends Is Giving Away His Top Income Secrets… FOR FREE! (Ad)
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Income Expert and Author of Get Rich With Dividends Is Giving Away His Top Income Secrets… FOR FREE! (Ad)
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
Stock market today: Asian shares mostly decline, while Tokyo again touches a record high
What recession? Professional forecasters raise expectations for US economy in 2024
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Income Expert and Author of Get Rich With Dividends Is Giving Away His Top Income Secrets… FOR FREE! (Ad)
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Income Expert and Author of Get Rich With Dividends Is Giving Away His Top Income Secrets… FOR FREE! (Ad)
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
Stock market today: Asian shares mostly decline, while Tokyo again touches a record high
What recession? Professional forecasters raise expectations for US economy in 2024
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Income Expert and Author of Get Rich With Dividends Is Giving Away His Top Income Secrets… FOR FREE! (Ad)
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Income Expert and Author of Get Rich With Dividends Is Giving Away His Top Income Secrets… FOR FREE! (Ad)
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
Stock market today: Asian shares mostly decline, while Tokyo again touches a record high
What recession? Professional forecasters raise expectations for US economy in 2024
NYSE:GKOS

Glaukos (GKOS) Stock Price, News & Analysis

$89.57
-1.89 (-2.07%)
(As of 02/23/2024 ET)
Today's Range
$88.49
$95.17
50-Day Range
$76.39
$96.42
52-Week Range
$44.26
$97.24
Volume
1.20 million shs
Average Volume
453,475 shs
Market Capitalization
$4.37 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$91.80

Glaukos MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.75 Rating Score
Upside/​Downside
2.5% Upside
$91.80 Price Target
Short Interest
Healthy
8.14% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.90
Upright™ Environmental Score
News Sentiment
0.37mentions of Glaukos in the last 14 days
Based on 32 Articles This Week
Insider Trading
Selling Shares
$22.17 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($2.13) to ($1.43) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.61 out of 5 stars

Medical Sector

268th out of 936 stocks

Surgical & Medical Instruments Industry

33rd out of 91 stocks


GKOS stock logo

About Glaukos Stock (NYSE:GKOS)

Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite, an implantable device intended to reduce the intraocular pressure of the eye; and iDose TR, a targeted injectable implant based on its micro-scale device-platform that is designed to deliver therapeutic levels of medication. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo California.

GKOS Stock Price History

GKOS Stock News Headlines

The perfect AI stock under $10
Normally, bringing a new drug to market takes an average of 10 years and between $2.5 and $12 billion. However, new AI technology has the potential to make the process up to 1000 times faster. This #1 AI company is at the forefront of it all.
Glaukos Stock (NYSE:GKOS), Short Interest Report
GKOS Apr 2024 47.500 put
Better Than Oil Stocks
The best way to profit from energy is NOT a stock...Rather, it's this little-known alternative investment. 
Glaukos (GKOS) Reports Q4 Loss, Tops Revenue Estimates
Glaukos Q4 2023 Earnings Preview
Glaukos (NYSE:GKOS) Upgraded to "Hold" by StockNews.com
Glaukos (GKOS) Set to Announce Earnings on Wednesday
Glaukos' (GKOS) "Buy" Rating Reiterated at Needham & Company LLC
GKOS Mar 2024 82.500 put
GKOS Apr 2024 130.000 call
Here's Why You Should Retain Glaukos (GKOS) Stock for Now
See More Headlines
Receive GKOS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Glaukos and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/21/2024
Today
2/25/2024
Next Earnings (Estimated)
5/01/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Employees
783
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$91.80
High Stock Price Target
$108.00
Low Stock Price Target
$65.00
Potential Upside/Downside
+2.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
8 Analysts

Profitability

Net Income
$-99,190,000.00
Pretax Margin
-42.49%

Debt

Sales & Book Value

Annual Sales
$314.71 million
Book Value
$9.46 per share

Miscellaneous

Free Float
44,994,000
Market Cap
$4.37 billion
Optionable
Optionable
Beta
1.11
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives















GKOS Stock Analysis - Frequently Asked Questions

Should I buy or sell Glaukos stock right now?

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Glaukos in the last twelve months. There are currently 2 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" GKOS shares.
View GKOS analyst ratings
or view top-rated stocks.

What is Glaukos' stock price target for 2024?

8 brokers have issued 1 year price targets for Glaukos' shares. Their GKOS share price targets range from $65.00 to $108.00. On average, they anticipate the company's share price to reach $91.80 in the next twelve months. This suggests a possible upside of 2.5% from the stock's current price.
View analysts price targets for GKOS
or view top-rated stocks among Wall Street analysts.

How have GKOS shares performed in 2024?

Glaukos' stock was trading at $79.49 at the beginning of 2024. Since then, GKOS stock has increased by 12.7% and is now trading at $89.57.
View the best growth stocks for 2024 here
.

Are investors shorting Glaukos?

Glaukos saw a drop in short interest in January. As of January 31st, there was short interest totaling 3,970,000 shares, a drop of 47.4% from the January 15th total of 7,550,000 shares. Based on an average daily trading volume, of 827,800 shares, the short-interest ratio is currently 4.8 days.
View Glaukos' Short Interest
.

When is Glaukos' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024.
View our GKOS earnings forecast
.

How were Glaukos' earnings last quarter?

Glaukos Co. (NYSE:GKOS) issued its quarterly earnings results on Wednesday, February, 21st. The medical instruments supplier reported ($0.63) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.56) by $0.07. The medical instruments supplier earned $82.40 million during the quarter, compared to analysts' expectations of $81 million. Glaukos had a negative trailing twelve-month return on equity of 22.67% and a negative net margin of 42.79%. The firm's revenue was up 15.7% on a year-over-year basis. During the same period in the prior year, the firm earned ($0.53) earnings per share.

What guidance has Glaukos issued on next quarter's earnings?

Glaukos issued an update on its FY 2024 earnings guidance on Friday, February, 2nd. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $350.0 million-$360.0 million, compared to the consensus revenue estimate of $352.7 million.

What is Thomas W. Burns' approval rating as Glaukos' CEO?

10 employees have rated Glaukos Chief Executive Officer Thomas W. Burns on Glassdoor.com. Thomas W. Burns has an approval rating of 100% among the company's employees. This puts Thomas W. Burns in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Glaukos own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Glaukos investors own include NVIDIA (NVDA), Marvell Technology (MRVL), PTC Therapeutics (PTCT), PayPal (PYPL), QUALCOMM (QCOM), Alibaba Group (BABA), Teladoc Health (TDOC), Intel (INTC), Advanced Micro Devices (AMD) and Boeing (BA).

When did Glaukos IPO?

(GKOS) raised $76 million in an initial public offering (IPO) on Thursday, June 25th 2015. The company issued 5,400,000 shares at $13.00-$15.00 per share. J.P. Morgan, BofA Merrill Lynch and Goldman Sachs acted as the underwriters for the IPO and William Blair and Cantor Fitzgerald were co-managers.

Who are Glaukos' major shareholders?

Glaukos' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (10.73%), Brown Capital Management LLC (5.53%), Artisan Partners Limited Partnership (2.51%), Dimensional Fund Advisors LP (1.89%), Primecap Management Co. CA (1.62%) and Riverbridge Partners LLC (1.12%). Insiders that own company stock include Alex R Thurman, Gilbert H Kliman, Joseph E Gilliam, Joseph E Gilliam, Marc Stapley and Thomas William Burns.
View institutional ownership trends
.

How do I buy shares of Glaukos?

Shares of GKOS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:GKOS) was last updated on 2/25/2024 by MarketBeat.com Staff